Prevalence of hand dysfunction in cerebral palsy following botulinum toxin therapy

被引:0
|
作者
Alahmar-Bianchin, M. [1 ]
Saraiva-Storti, H. C. [1 ]
Fornari-Chueire, R. [1 ]
Lucato, R. V., Jr. [1 ]
机构
[1] Fac Med, BR-15090040 Sao Jose do Rio Preto, SP, Brazil
关键词
botulinum toxin; cerebral palsy; functional independence; hand functioning; occupational therapy; proprioception;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim. To examine the level of dependence, the functional class, the most frequent type of compromise and the proprioception of the hand in spastic cerebral palsy following the application of botulinum toxin, as well as to determine the socio-demographic characteristics of the individuals involved. Patients and methods. We conducted a cross-sectional study of 21 spastic patients with extrinsic muscle involvement, of both sexes and a mean age of 15.4 +/- 5.6 years, who attended the neuro-rehabilitation outpatients department and were treated with botulinum toxin in the muscles responsible for the functional movements in the hand; they were evaluated after a mean period of 2.1 years. Patients were subjected to procedures such as a semi-structured interview, the FIM (Functional Independence Measurement) scale, Hausen's functional characterisation, Zancolli classification and a proprioception test. Results. There was a predominance of females (57% of patients) and of a basic level of schooling. On the FIM scale, 38% of the patients presented modified independence, without help; 23.8% belonged to Hansen grade 3 (grasping and holding an object steady with the help of the other hand). On the Zancolli classification, 54% belonged to type III (the fingers can only be extended if the fist is bent more than 70 degrees); perception of movement is absent (76.2%) and the sense of position of the movement is altered (54.2%). Conclusions. Findings confirmed the existence of a high rate of modified independence, grade 3 (Hausen), together with type III involvement (Zancolli) and alterations affecting proprioception. Data from the study show the importance of occupational therapy as part of the care received by patients with cerebral palsy following the administration of botulinum toxin type A.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 50 条
  • [1] Botulinum toxin as a therapy for cerebral palsy
    Raj, S. A.
    Adithya, S.
    Shanker, A.
    Ahmad, F.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2024, 19 (04): : 135 - 141
  • [2] Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy
    Naidu, Krishant
    Smith, Katherine
    Sheedy, Mary
    Adair, Brooke
    Yu, Xavier
    Graham, H. Kerr
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2010, 52 (02): : 139 - 144
  • [3] Systemic Adverse Events Following Botulinum Toxin A Therapy in Children With Cerebral Palsy
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2011, 185 (06): : 2347 - 2347
  • [4] Botulinum toxin A and cerebral palsy
    Jabbari, B
    Latimer, E
    Clapp, L
    Shrantz, W
    McHale, K
    Coll, D
    NEUROLOGY, 1998, 50 (04) : A366 - A367
  • [5] Botulinum toxin in cerebral palsy
    Fietzek, U.
    Mall, V.
    NERVENHEILKUNDE, 2010, 29 (09) : 545 - +
  • [6] Analysis of the effects of functional electrical stimulation on gait in cerebral palsy following botulinum toxin therapy
    Gregoric, M
    Damjan, H
    Gros, N
    Klemen, A
    Tomsic, I
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2004, 27 : 120 - 121
  • [7] Botulinum toxin as treatment of cerebral palsy
    PascualPascual, SI
    deMuniain, PS
    Roche, MC
    PascualCastroviejo, I
    REVISTA DE NEUROLOGIA, 1997, 25 (145) : 1369 - 1375
  • [8] Botulinum toxin for drooling in cerebral palsy
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (04) : 338 - 338
  • [9] Botulinum toxin in children with cerebral palsy
    Singhi P.
    Ray M.
    The Indian Journal of Pediatrics, 2004, 71 (12) : 1087 - 1091
  • [10] Botulinum toxin in the management of cerebral palsy
    Cosgrove, AP
    EUROPEAN JOURNAL OF NEUROLOGY, 1995, 2 : 73 - 80